Renescience A/S: Financial statements 2021
CVR: 31846803
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Renescience A/S (CVR 31846803) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 7,970,000 and a net result of DKK -8,322,000 compared with DKK -13,492,000 the year before. That is an increase of 371% compared with the year before. The profit margin was -104.4%. Equity in the 2021 report amounted to DKK 22,754,000. The solvency ratio was 63.3%.
- Revenue
- DKK 7,970,000
- Gross Profit
- DKK -11,415,000
- Profit/Loss
- DKK -8,322,000
- Equity
- DKK 22,754,000
- Total Assets
- DKK 35,921,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 8 mio. | -11.4 mio. | -8.3 mio. | 22.8 mio. | - |
| 2020 | 1.7 mio. | -16.6 mio. | -13.5 mio. | 31.1 mio. | - |
| 2019 | - | -23.2 mio. | -18.1 mio. | 44.6 mio. | - |
| 2018 | - | -24.3 mio. | -19.1 mio. | 62.7 mio. | - |
| 2017 | - | -9.7 mio. | -7.8 mio. | 81.8 mio. | - |
Official annual report
Find more companies like Renescience A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Renescience A/S has published its annual report for 2020. Revenue came to DKK 1,692,000, and the net result was DKK -13,492,000.
As of February 15, 2021, Mikael Brandt has joined the board of directors of Renescience A/S.
As of February 15, 2021, Hanne Risbjerg Sørensen has joined the board of directors of Renescience A/S.
As of February 15, 2021, Morten Hultberg Buchgreitz has left the board of directors of Renescience A/S.
As of February 14, 2021, Mikael Brandt has left the board of directors of Renescience A/S.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RENESCIENCE A/S and DE S&D NR. 1 2008 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. According to the 2025 annual report, the company had an average of 1,000 employees. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity in the 2025 report amounted to DKK 73,470,000.